LUNGevity Foundation shared a post on LinkedIn:
“Healthcare providers – testing for all clinically recommended biomarkers is a critical step for your non-small cell lung cancer patients. The results of comprehensive biomarker testing can help inform their treatment that may prevent their NSCLC from growing or spreading. Discover our resources for more information.”
Proceed to the video attached to the post.
More posts featuring LUNGevity Foundation.